Développement d'un immunoliposome de docétaxel-trastuzumab dans le cancer du sein

Développement d'un immunoliposome de docétaxel-trastuzumab dans le cancer du sein

Les nanotechnologies appliquées à la médecine, et plus particulièrement à l’oncologie, ont permis le développement d’une nouvelle classe d’entités, appelées communément nanomédicaments ou médicaments vectorisés. Ce projet de recherche a pour objectif d’encapsuler du docétaxel dans un vecteur lipidiq...

Full description

Bibliographic Details
Main Author:	Rodallec, Anne
Other Authors:	Aix-Marseille
Language:	fr en
Published:	2018
Subjects:	Immunoliposome Nanomédecine Biodistribution Xénogreffes Cancer du sein Trastuzumab Docétaxel Nanomedicine Xenografts Breast cancer Docetaxel
Online Access:	http://www.theses.fr/2018AIXM0434/document

Similar Items

From 3D spheroids to tumor bearing mice: efficacy and distribution studies of trastuzumab-docetaxel immunoliposome in breast cancer
by: Rodallec A, et al.
Published: (2018-10-01)

Docetaxel-trastuzumab stealth immunoliposome: development and in vitro proof of concept studies in breast cancer
by: Rodallec A, et al.
Published: (2018-06-01)

Docetaxel-Loaded Chitosan Microspheres as a Lung Targeted Drug Delivery System: In Vitro and in Vivo Evaluation
by: Hao Wang, et al.
Published: (2014-02-01)

Lipossomas e imunolipossomas contendo fármacos antitumorais: desenvolvimento, caracterização e avaliação da eficácia contra o câncer de mama
by: Josimar de Oliveira Eloy
Published: (2016)

Lipossomas e imunolipossomas contendo fármacos antitumorais: desenvolvimento, caracterização e avaliação da eficácia contra o câncer de mama
by: Eloy, Josimar de Oliveira
Published: (2016)

Immunoliposomes with Simvastatin as a Potential Therapeutic in Treatment of Breast Cancer Cells Overexpressing HER2—An In Vitro Study
by: Lucyna Matusewicz, et al.
Published: (2018-11-01)

Enhanced Antisense Oligonucleotide Delivery Using Cationic Liposomes Grafted with Trastuzumab: A Proof-of-Concept Study in Prostate Cancer
by: Guillaume Sicard, et al.
Published: (2020-11-01)

Vectorisation du 6BrCaQ, un inhibiteur potentiel de hsp90, par des liposomes pour le traitement du cancer
by: Sauvage, Félix
Published: (2016)

Roles of adipocytes in the resistance of breast cancer to trastuzumab-mediated antibody-dependent cellular cytotoxicity (ADCC)
by: Duong, Minh Ngoc
Published: (2014)

Repeated Exposure to Cationic Immunoliposomes Activates Effective Gene Transfer to Human Glioma Cells
by: MIZUNO, Masaaki, et al.
Published: (1996)

SATB1 siRNA-encapsulated immunoliposomes conjugated with CD44 antibodies target and eliminate gastric cancer-initiating cells
by: Yang F, et al.
Published: (2018-10-01)

Trastuzumab-induced thrombocytopenia after eight cycles of trastuzumab treatment
by: Zhou Qiong, et al.
Published: (2020-07-01)

The Stem Cell Phenotype of Aggressive Breast Cancer Cells
by: Naira V. Margaryan, et al.
Published: (2019-03-01)

Development of the CK‐MB‐1 trastuzumab‐resistant HER2‐positive breast cancer cell line and xenograft animal models
by: Wei‐Pang Chung, et al.
Published: (2021-04-01)

Trastuzumab Cures Cancer and Disrupts the Practice of Cardiology∗
by: Richard M. Steingart, MD, et al.
Published: (2019-09-01)

Modélisation de l'évolution de la taille tumorale par l'analyse de population : application au cancer du sein métastatique traité par l'association docetaxel-capécitabine
by: Frances, Nicolas
Published: (2010)

Drug Conjugates Such as Antibody Drug Conjugates (ADCs), Immunotoxins and Immunoliposomes Challenge Daily Clinical Practice
by: Christoph Mamot, et al.
Published: (2012-11-01)

Dual Targeting of Tumor Cells with Bispecific Single-Chain Fv-Immunoliposomes
by: Katharina Mack, et al.
Published: (2012-07-01)

Caractérisation des cellules souches cancéreuses des sous types luminaux dans le cancer du sein
by: Nguyen, Tien Tuan
Published: (2013)

Lapatinib in combination with capecitabine versus continued use of trastuzumab in breast cancer patients with trastuzumab-resistance: a retrospective study of a Chinese population
by: Fan Yang, et al.
Published: (2020-03-01)

Trastuzumabe no câncer de mama metastático: uma revisão sistemática da razão custo-efetividade
by: Andrade, Thays Santos de
Published: (2017)

Trastuzumabe no câncer de mama metastático: uma revisão sistemática da razão custo-efetividade
by: Andrade, Thays Santos de
Published: (2017)

Construction and characterization of immunoliposomes targeting fibroblast growth factor receptor 3
by: Zhong Zheng, et al.
Published: (2019-09-01)

Interstitial Pneumonitis Secondary to Trastuzumab: A Case Report and Literature Review
by: Ricardo Costa, et al.
Published: (2017-06-01)

Comparison of the measured biodistribution of 212Pb-radiolabeled monoclonal antibodies (Trastuzumab) in mice with 232Th and progeny in human reticuloendothelial tissue measured using alpha particle track autoradiographic microdosimetry from Thorotrast
by: Schneider, Nathaniel R.
Published: (2019)

Développement d'anticorps bispécifiques de lama pour le traitement de cancers du sein réfractaires à l'action du trastuzumab
by: Turini, Marc
Published: (2014)

Relationship Between Docetaxel AUC and Neutropenia in Patients with Breast Cancer
by: ZHANG Ni, et al.
Published: (2018-05-01)

Safety of Continuing Trastuzumab Despite Mild Cardiotoxicity
by: Darryl P. Leong, MBBS, MPH, MBiostat, PhD, et al.
Published: (2019-09-01)

Modulation of the Microtubule Network for Optimization of Nanoparticle Dynamics for the Advancement of Cancer Nanomedicine
by: Aaron Bannister, et al.
Published: (2020-06-01)

Assessment of Carvedilol Therapy in Prevention of Heart Failure in HER2 Positive Breast Cancer Patients Receiving Trastuzumab
by: Alborz Sherafati, et al.
Published: (2019-05-01)

Docetaxel for Breast Cancer Treatment-Side Effects on Ocular Surface, a Systematic Review
by: Elena Andreea Stoicescu, et al.
Published: (2021-06-01)

Short-course adjuvant trastuzumab will increase cure rates in patients with human epidermal growth factor receptor 2-positive breast cancer
by: Raymond Pierre Abratt
Published: (2017-08-01)

Targeting Chronic Myeloid Leukemia Stem/Progenitor Cells Using Venetoclax-Loaded Immunoliposome
by: Mohammad Houshmand, et al.
Published: (2021-03-01)

Modelling hypersensitivity to trastuzumab defines biomarkers of response in HER2 positive breast cancer
by: Laura Díaz-Gil, et al.
Published: (2021-10-01)

Early cardiotoxicity after adjuvant concomitant treatment with radiotherapy and trastuzumab in patients with breast cancer
by: Marinko Tanja, et al.
Published: (2018-02-01)

Effectiveness of adjuvant trastuzumab in daily clinical practice
by: Matos Erika, et al.
Published: (2014-12-01)

Use of trastuzumab in treating breast cancer during pregnancy: a systematic review and meta-analysis
by: Lin-Yu Xia, et al.
Published: (2021-04-01)

Design of theranostic nanomedicine (II): synthesis and physicochemical properties of a biocompatible polyphosphazene–docetaxel conjugate
by: Jun YJ, et al.
Published: (2017-07-01)

Trastuzumab-Induced Myocardiotoxicity Mimicking Acute Coronary Syndrome
by: K.B. Ribeiro, et al.
Published: (2012-03-01)

Severe Photo Toxicity Recalled by Docetaxel
by: Emma K. Johansson, et al.
Published: (2018-11-01)